Novo Nordisk in Exclusive Talks to Acquire French Device-Maker Biocorp for $165M

Bagsvaerd, Denmark, June 5, 2023 (MedTech) -- Novo Nordisk, a leading pharmaceutical company specializing in insulin pens, is engaged in exclusive discussions to purchase French medical device company Biocorp. The acquisition aims to strengthen Novo Nordisk's innovation capabilities in connected devices and drug delivery solutions, building upon their existing collaboration on a smart pen cap that tracks injection data.

Read full article here.